Статины значимо снижают риск развития рака пищевода и печени, гематологического рака и лейкемии

JACC Journals › JACC: CardioOnc › Archives › Vol. 7 No. 5 Bidirectional Cardio-Oncology Focus Issue 19 August 2025 Cancer and Cardiovascular Disease: Shared Risk Factors, Mechanisms, and Clinical Implications: JACC: CardioOncology State-of-the-Art Review Yuan F., Wen W., Jia G., Long J., Shu X.O., Zheng W. Serum lipid profiles and cholesterol-lowering medication use in relation to subsequent risk of colorectal cancer in the UK Biobank cohort. Cancer Epidemiol Biomarkers Prev. 2023;32:4: 524-530. Navarese E.P., Robinson J.G., Kowalewski M., et al. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis. JAMA. 2018;319:15: 1566-1579. Ganjali S., Banach M., Pirro M., Fras Z., Sahebkar A. HDL and cancer - causality still needs to be confirmed? Update 2020. Semin Cancer Biol. 2021;73:169-177.